Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Núria Jordana‐Ariza"'
Autor:
Miguel Angel Molina-Vila, Niki Karachaliou, Umberto Malapelle, Clara Mayo-de-las-Casas, Mónica Garzón Ibañez, Giancarlo Troncone, Ariadna Balada-Bel, Beatriz García-Peláez, Núria Jordana-Ariza, Sergio Villatoro, Rafael Rosell
Publikováno v:
Expert Review of Molecular Diagnostics. 18:35-45
Collection of tumor samples is not always feasible in non-small cell lung cancer (NSCLC) patients, and circulating free DNA (cfDNA) extracted from blood represents a viable alternative. Different sensitive platforms have been developed for genetic cf
Autor:
Raquel Campos, Mónica Garzón, Xavier Gonzalez, Miguel Angel Molina-Vila, Maria-de-los-Llanos Gil, Rafael Rosell, Clara Mayo-de-las-Casas, Ariadna Balada, Daniela Morales-Espinosa, Ana Pérez-Rosado, Maria José Catalán, Ana Giménez-Capitán, Núria Jordana-Ariza, Cristina Aguado, Cristina Teixidó, Santiago Viteri, Maria Gonzalez-Cao, Sergi Villatoro, Jordi Bertran-Alamillo, Alejandro Martinez-Bueno, Niki Karachaliou, Beatriz García-Peláez
Publikováno v:
Frontiers in Medicine
Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached it
Autor:
Miguel Angel Molina-Vila, Núria Jordana-Ariza, Carlos Camps, Eloisa Jantus-Lewintre, Rafael Rosell, Clara Mayo de las Casas, Ariadna Balada, Silvia Calabuig-Fariñas, Ana Blasco
Publikováno v:
Journal of Clinical Oncology. 34:e23039-e23039
e23039Background: One of the most promising developments in translational cancer has been the emergence of liquid biopsy as a non-invasive biomarker. CTCs and cfDNA offer valuable prognostic and pr...